Matsumoto M, Matsubara S, Matsuno T, Ono M, Yokota T
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Company, Shizuoka.
Microbiol Immunol. 1990;34(9):765-73. doi: 10.1111/j.1348-0421.1990.tb01054.x.
Protective effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on microbial infections was studied in cyclophosphamide (CPA)-induced neutropenic mice. The neutropenic mice showed severely decreased resistance against systemic infections of Pseudomonas aeruginosa, Escherichia coli, Serratia marcescens, Staphylococcus aureus, and Candida albicans. When such mice were injected subcutaneously with rG-CSF on four consecutive days beginning the day after CPA injection, the decreased anti-microbial resistance of the mice was restored to the level of that in normal mice. The anti-infective effect of rG-CSF was dose-dependent and the 50% effective doses (ED50) in various microbial infections tested were 1-10 micrograms/kg/day. The results suggest that rG-CSF is useful for protection of neutropenic patients from microbial infections.
在环磷酰胺(CPA)诱导的中性粒细胞减少小鼠中研究了重组人粒细胞集落刺激因子(rG-CSF)对微生物感染的保护作用。中性粒细胞减少小鼠对铜绿假单胞菌、大肠杆菌、粘质沙雷氏菌、金黄色葡萄球菌和白色念珠菌的全身感染抵抗力严重下降。当在CPA注射后第二天开始连续四天给这些小鼠皮下注射rG-CSF时,小鼠降低的抗微生物抵抗力恢复到正常小鼠的水平。rG-CSF的抗感染作用呈剂量依赖性,在各种测试的微生物感染中50%有效剂量(ED50)为1-10微克/千克/天。结果表明,rG-CSF有助于保护中性粒细胞减少患者免受微生物感染。